Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yvan Vial is active.

Publication


Featured researches published by Yvan Vial.


Obstetrics & Gynecology | 2001

Prenatal diagnosis of congenital cytomegalovirus infection

Ahmad-Zalmai Azam; Yvan Vial; Claire-Lise Fawer; Jade Zufferey; Patrick Hohlfeld

Objective To assess prospectively the diagnostic reliability and prognostic significance of prenatal diagnosis of cytomegalovirus (CMV) infection. Methods One hundred ten pregnant women (four with twin pregnancies) with a risk of congenital CMV infection were investigated. Prenatal diagnosis was carried out by amniocentesis and fetal blood sampling (n = 75) or amniocentesis alone (n = 35). Serial ultrasonographic examinations were performed from time of referral until pregnancy end. All infected neonates were given long-term follow-up. Autopsy was performed in all cases of termination of pregnancy. Results Nearly 23% (26 of 114) of fetuses were infected and prenatal diagnosis was positive in 20 cases. Sensitivity of prenatal diagnosis was 77% and specificity 100%. In eight cases, parents requested termination of pregnancy on the basis of abnormal ultrasonographic findings and/or biologic abnormalities in fetal blood. In 12 cases, parents decided to proceed with the pregnancy. In this group, one intrauterine and one neonatal death were observed. In one case, prenatal diagnosis revealed an abnormal cerebral sonography and the infant had bilateral hearing loss at birth. In 15 cases (nine positive and six false-negative prenatal diagnoses), no apparent lesion was present at birth, nor did it develop during the follow-up period (mean 31 months). In 88 (77.2%) of 114 infants, no evidence of vertical transmission was found during the pre- or postnatal period. Conclusion Prenatal diagnosis provides the optimal means for both diagnosing fetal infection (amniocentesis) and identifying fetuses at risk of severe sequelae (ultrasound examination, fetal blood sampling), thus allowing proper counseling.


Emerging Infectious Diseases | 2011

Role of Chlamydia trachomatis in Miscarriage

David Baud; Genevieve Goy; Katia Jaton; Maria-Chiara Osterheld; Serafin Blumer; Nicole Borel; Yvan Vial; Patrick Hohlfeld; Andreas Pospischil; Gilbert Greub

TOC Summary: Women experiencing miscarriage should be screened for C. trachomatis.


European Journal of Obstetrics & Gynecology and Reproductive Biology | 2000

Screening for gestational diabetes: variation in guidelines.

Nicolas Vogel; Bernard Burnand; Yvan Vial; Juan Ruiz; Fred Paccaud; Patrick Hohlfeld

OBJECTIVE To compare published guidelines concerning screening for gestational diabetes. STUDY DESIGN Systematic search and comparative analysis of published guidelines. Appraisal of guidelines quality. Simulation analysis. RESULTS Ten published guidelines proposed either universal screening (5), selective screening (3) or screening when clinically indicated (2). Variations of testing schedules and blood glucose thresholds were observed. The quality of the published guidelines was low, on average 22 (8-51) percentage points on the assessment scale. These differences would have led to large variations in the number of patients to be screened. CONCLUSIONS Large variations between guidelines have been observed which would translate in large practice variations, if the guidelines were systematically applied. These variations are partially explained by the absence of definite evidence that universal or selective screening for gestational diabetes do more good than harm on infant and maternal health. The methodology of developing guidelines should be more evidence based, systematic and explicit.


British Journal of Haematology | 1999

Haematological parameters of parvovirus B19 infection in 13 fetuses with hydrops foetalis

François Forestier; Jean-Daniel Tissot; Yvan Vial; Fernand Daffos; Patrick Hohlfeld

Thirteen cases of fetal parvovirus B19 infection with hydrops foetalis are reported. Viral DNA was identified by polymerase chain reaction (PCR) of amniotic fluid sampled between the 19th and the 29th week of gestation. Haematological examination revealed severe anaemia in all cases and thrombocytopenia in 11/13 cases, which was severe in two cases. Six fetuses died in utero; two after intrauterine transfusion. Complete recovery was observed in seven fetuses; five cases were treated by intrauterine transfusions, and in two cases spontaneous recovery occurred. Upon follow‐up, no case of congenital anaemia was observed.


European Journal of Radiology | 2010

Fetal MRI as complement to US in the diagnosis and characterization of anomalies of the genito-urinary tract

Leonor Alamo; Tarek Laswad; Pierre Schnyder; Reto Meuli; Yvan Vial; Maria-Chiara Osterheld; François Gudinchet

The purpose of this study is to compare the accuracy of prenatal ultrasound (US) and prenatal magnetic resonance imaging (MRI) in the diagnosis and characterization of congenital abnormalities of the genito-urinary tract and to determine if the additional information obtained by MRI may influence the management of the fetus. We retrospectively evaluate 15 cases of congenital genito-urinary tract anomalies detected by prenatal US and with echographic inconclusive diagnosis. We compare the MRI findings with the US findings and the final diagnosis, obtained from neonatal outcomes, imaging studies and pathology records. Fetal US diagnosis was correct in 9 cases (60%) and MRI in 13 cases (86.7%). Prenatal MRI revealed additional information to US in 9 cases (60%), which modified the initial US diagnosis in 5 cases (33.3%) and changed the therapeutic approach in 5 fetuses (33.3%). Fetal MRI was better than US in cases of oligoamnios and in fetuses with genito-urinary pathology concerning the pelvic and perineum region. We believe that MRI should be considered as a complementary diagnostic method in cases of echographic suspicion of congenital pathology of the genito-urinary tract and inconclusive prenatal US.


Emerging Infectious Diseases | 2014

Role of Waddlia chondrophila placental infection in miscarriage.

David Baud; Genevieve Goy; Maria-Chiara Osterheld; Antony Croxatto; Nicole Borel; Yvan Vial; Andreas Pospischil; Gilbert Greub

Waddlia chondrophila is an intracellular bacterium suspected to cause human and bovine abortion. We confirmed an association between antibodies against W. chondrophila and human miscarriage and identified this organism in placenta or genital tract of women who had had miscarriages. These results suggest a possible role of W. chondrophila infection in miscarriage.


Cardiology in The Young | 2010

Considerations for Prenatal Counselling of Patients with Cardiac Rhabdomyomas based on their Cardiac and Neurologic Outcomes

Sabrina C. Degueldre; Priya Chockalingam; Yvan Mivelaz; Stefano Di Bernardo; Jean-Pierre Pfammatter; Catherine Barréa; Nicole Sekarski; Pierre-Yves Jeannet; Jean-Claude Fouron; Yvan Vial; Erik Jan Meijboom

Cardiac rhabdomyomas are benign cardiac tumours with few cardiac complications, but with a known association to tuberous sclerosis that affects the neurologic outcome of the patients. We have analysed the long-term cardiac and neurological outcomes of patients with cardiac rhabdomyomas in order to allow comprehensive prenatal counselling, basing our findings on the records of all patients seen prenatally and postnatally with an echocardiographic diagnosis of cardiac rhabdomyoma encountered from August, 1982, to September, 2007. We analysed factors such as the number and the location of the tumours to establish their association with a diagnosis of tuberous sclerosis, predicting the cardiac and neurologic outcomes for the patients.Cardiac complications include arrhythmias, obstruction of the ventricular outflow tracts, and secondary cardiogenic shock. Arrhythmias were encountered most often during the neonatal period, with supraventricular tachycardia being the commonest rhythm disturbance identified. No specific dimension or location of the cardiac rhabdomyomas predicted the disturbances of rhythm.The importance of the diagnosis of tuberous sclerosis is exemplified by the neurodevelopmental complications, with four-fifths of the patients showing epilepsy, and two-thirds having delayed development. The presence of multiple cardiac tumours suggested a higher risk of being affected by tuberous sclerosis. The tumours generally regress after birth, and cardiac-related problems are rare after the perinatal period. Tuberous sclerosis and the associated neurodevelopmental complications dominate the clinical picture, and should form an important aspect of the prenatal counselling of parents.


Expert Opinion on Drug Safety | 2015

Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.

Etienne Weisskopf; Céline J. Fischer; Myriam Bickle Graz; Mathilde Morisod Harari; Jean-François Tolsa; Olivier Claris; Yvan Vial; Chin B. Eap; Chantal Csajka; Alice Panchaud

Introduction: Psychiatric disorders are among the leading causes of disability in Western societies. Selective serotonin reuptake inhibitors (SSRIs) are the most frequently prescribed antidepressant drugs during pregnancy and the postpartum period. Over the last decade, conflicting findings regarding the safety of SSRI drugs during pregnancy and lactation have questioned whether such treatments should be used during this period. Areas covered: We discuss the main criteria that should be considered in the risk/benefit assessment of SSRI treatment in pregnant and/or breastfeeding patients (i.e., risks associated with SSRI use and with untreated depression as well as therapeutic benefits of SSRI and some alternative treatment strategies). For each criterion, available evidence has been synthesized and stratified by methodological quality as well as discussed for clinical impact. Expert opinion: Currently, it is impossible for most of the evaluated outcomes to distinguish between the effects related to the mother’s underlying disease and those inherent to SSRI treatment. In women suffering from major depression and responding to a pharmacological treatment, introduction or continuation of an SSRI should be encouraged in order to prevent maternal complications and to preserve maternal–infant bonding. The choice of the right drug depends above all on individual patient characteristics such as prior treatment response, diagnoses and comorbid conditions.


Pediatric Radiology | 2012

Prenatal diagnosis of congenital lung malformations

Leonor Alamo; François Gudinchet; Olivier Reinberg; Yvan Vial; Katyuska Francini; Maria-Chiara Osterheld; Reto Meuli

Prenatal diagnosis of congenital lung anomalies has increased in recent years as imaging methods have benefitted from technical improvements. The purpose of this pictorial essay is to illustrate typical imaging findings of a wide spectrum of congenital lung anomalies on prenatal US and MRI. Moreover, we propose an algorithm based on imaging findings to facilitate the differential diagnosis, and suggest a follow-up algorithm during pregnancy and in the immediate postnatal period.


British Journal of Obstetrics and Gynaecology | 2004

Spontaneous delivery or manual removal of the placenta during caesarean section: a randomised controlled trial

Michel Morales; Gilles Ceysens; Nicole Jastrow; Caroline Viardot; Gilles Faron; Yvan Vial; Christine Kirkpatrick; Olivier O. Irion; Michel Boulvain

Objective  To compare blood loss with spontaneous delivery and manual removal of the placenta during caesarean section.

Collaboration


Dive into the Yvan Vial's collaboration.

Top Co-Authors

Avatar

Patrick Hohlfeld

University Hospital of Lausanne

View shared research outputs
Top Co-Authors

Avatar

David Baud

University Hospital of Lausanne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leonor Alamo

University Hospital of Lausanne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gilbert Greub

University Hospital of Lausanne

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Reto Meuli

University Hospital of Lausanne

View shared research outputs
Researchain Logo
Decentralizing Knowledge